XBiotech Inc. (XBIT)
USD 2.74
(-7.12%)
USD 2.74
(-7.12%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -200.02 Million USD | -27.16% |
| 2022 | -157.3 Million USD | 33.62% |
| 2021 | -236.98 Million USD | 0.16% |
| 2020 | -237.36 Million USD | 66.78% |
| 2019 | -714.59 Million USD | -4416.17% |
| 2018 | -15.82 Million USD | 50.19% |
| 2017 | -31.76 Million USD | 7.45% |
| 2016 | -34.32 Million USD | 62.3% |
| 2015 | -91.05 Million USD | -58.82% |
| 2014 | -57.32 Million USD | -691.4% |
| 2013 | -7.24 Million USD | -73.88% |
| 2012 | -4.16 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -178.53 Million USD | 6.55% |
| 2024 Q1 | -191.03 Million USD | 4.49% |
| 2023 FY | -200.02 Million USD | -27.16% |
| 2023 Q3 | -202.19 Million USD | -41.01% |
| 2023 Q1 | -152.48 Million USD | 3.07% |
| 2023 Q2 | -143.39 Million USD | 5.96% |
| 2023 Q4 | -200.02 Million USD | 1.07% |
| 2022 Q1 | -231.82 Million USD | 2.18% |
| 2022 FY | -157.3 Million USD | 33.62% |
| 2022 Q4 | -157.3 Million USD | 2.03% |
| 2022 Q3 | -160.56 Million USD | 28.89% |
| 2022 Q2 | -225.79 Million USD | 2.6% |
| 2021 Q3 | -238.87 Million USD | 24.23% |
| 2021 FY | -236.98 Million USD | 0.16% |
| 2021 Q1 | -239.87 Million USD | -1.06% |
| 2021 Q2 | -315.25 Million USD | -31.42% |
| 2021 Q4 | -236.98 Million USD | 0.79% |
| 2020 FY | -237.36 Million USD | 66.78% |
| 2020 Q2 | -229.7 Million USD | 4.9% |
| 2020 Q4 | -237.36 Million USD | 0.45% |
| 2020 Q3 | -238.43 Million USD | -3.8% |
| 2020 Q1 | -241.54 Million USD | 66.2% |
| 2019 Q4 | -714.59 Million USD | -1671.52% |
| 2019 FY | -714.59 Million USD | -4416.17% |
| 2019 Q1 | -12.01 Million USD | 24.04% |
| 2019 Q2 | -44.92 Million USD | -273.75% |
| 2019 Q3 | -40.33 Million USD | 10.2% |
| 2018 Q3 | -20.84 Million USD | 16.1% |
| 2018 Q4 | -15.82 Million USD | 24.11% |
| 2018 Q2 | -24.84 Million USD | 12.55% |
| 2018 FY | -15.82 Million USD | 50.19% |
| 2018 Q1 | -28.41 Million USD | 10.55% |
| 2017 FY | -31.76 Million USD | 7.45% |
| 2017 Q1 | -54.63 Million USD | -59.17% |
| 2017 Q2 | -45.94 Million USD | 15.89% |
| 2017 Q3 | -38.97 Million USD | 15.17% |
| 2017 Q4 | -31.76 Million USD | 18.5% |
| 2016 Q1 | -78.22 Million USD | 14.09% |
| 2016 FY | -34.32 Million USD | 62.3% |
| 2016 Q4 | -34.32 Million USD | 26.65% |
| 2016 Q3 | -46.79 Million USD | 27.79% |
| 2016 Q2 | -64.79 Million USD | 17.16% |
| 2015 Q1 | -52.23 Million USD | 8.88% |
| 2015 Q3 | -105.68 Million USD | 9.97% |
| 2015 FY | -91.05 Million USD | -58.82% |
| 2015 Q4 | -91.05 Million USD | 13.84% |
| 2015 Q2 | -117.38 Million USD | -124.71% |
| 2014 Q4 | -57.32 Million USD | -269.94% |
| 2014 Q1 | 7.24 Million USD | 200.0% |
| 2014 FY | -57.32 Million USD | -691.4% |
| 2014 Q3 | -15.49 Million USD | 0.0% |
| 2013 Q4 | -7.24 Million USD | 0.0% |
| 2013 FY | -7.24 Million USD | -73.88% |
| 2012 FY | -4.16 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -257.567% |
| Alkermes plc | -166.73 Million USD | -19.962% |
| Agenus Inc. | 274.13 Million USD | 172.965% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 110.697% |
| Aptorum Group Limited | 1.35 Million USD | 14839.589% |
| Ardelyx, Inc. | 34.51 Million USD | 679.575% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4773.435% |
| Bicycle Therapeutics plc | -481.46 Million USD | 58.456% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 653.115% |
| ChromaDex Corporation | -24.04 Million USD | -731.766% |
| Chimerix, Inc. | -25.51 Million USD | -683.881% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2970.563% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -744.799% |
| CRISPR Therapeutics AG | -150.84 Million USD | -32.602% |
| Precision BioSciences, Inc. | -85.41 Million USD | -134.192% |
| Dyadic International, Inc. | -6.37 Million USD | -3036.091% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1155.401% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2709.563% |
| Lantern Pharma Inc. | -21.7 Million USD | -821.626% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -80.956% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2241.319% |
| Incyte Corporation | -3.17 Billion USD | 93.7% |
| IO Biotech, Inc. | -140.69 Million USD | -42.164% |
| Jaguar Health, Inc. | 29.39 Million USD | 780.559% |
| Novavax, Inc. | -298.29 Million USD | 32.944% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3847.855% |
| Opthea Limited | 28.15 Million USD | 810.373% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1091.393% |
| ContextLogic Inc. | -232 Million USD | 13.783% |
| MiMedx Group, Inc. | -33.9 Million USD | -490.021% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2061.972% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -8532.744% |
| NextCure, Inc. | -6.47 Million USD | -2988.204% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -296.077% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3035.648% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1744.484% |
| Vaxcyte, Inc. | -368.22 Million USD | 45.679% |
| PDS Biotechnology Corporation | -32.7 Million USD | -511.525% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1257.674% |
| Pharming Group N.V. | 109.8 Million USD | 282.164% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1049.822% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -14.149% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -980.046% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -980.046% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2717.225% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3313.362% |
| Acelyrin, Inc. | -216.9 Million USD | 7.782% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3465.303% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -11502.262% |
| Summit Therapeutics Inc. | 34.67 Million USD | 676.867% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2840.218% |
| Senti Biosciences, Inc. | 1.74 Million USD | 11595.575% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -8.351% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -158.257% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3199.621% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 200586.123% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 31950.796% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -70.893% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -18.896% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 280.412% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2533.268% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -54.92% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3001.155% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 17.47% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1042.349% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 36.842% |
| MEI Pharma, Inc. | -3.7 Million USD | -5298.731% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1698.777% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 223.668% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 819.688% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2709.563% |
| Precigen, Inc. | -481 Thousand USD | -41484.823% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1520.517% |
| AlloVir, Inc. | -62.69 Million USD | -219.057% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -259.663% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 424.365% |
| ImmuCell Corporation | 10.99 Million USD | 1919.952% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -29.762% |
| Onconetix, Inc. | 5.33 Million USD | 3851.765% |
| PureTech Health plc | -167.19 Million USD | -19.633% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -556.674% |
| Elevation Oncology, Inc. | -19.11 Million USD | -946.255% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3974.618% |
| Seer, Inc. | -4.24 Million USD | -4617.524% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -732.146% |
| Innoviva, Inc. | 255.56 Million USD | 178.268% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -258.053% |
| ESSA Pharma Inc. | -33.62 Million USD | -494.924% |
| GlycoMimetics, Inc. | -40.98 Million USD | -388.046% |
| GT Biopharma, Inc. | -1.02 Million USD | -19490.891% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -195.093% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 426.531% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -49.183% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1343.584% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -592.792% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -265414.907% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -548.121% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2340.836% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -6292.517% |
| Soligenix, Inc. | -4.95 Million USD | -3939.565% |
| Century Therapeutics, Inc. | 847 Thousand USD | 23715.466% |
| Kura Oncology, Inc. | -20.11 Million USD | -894.249% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -388.743% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2281.793% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 11080.049% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -6156.584% |
| Autolus Therapeutics plc | -186.59 Million USD | -7.194% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -305.693% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 27.474% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 683.702% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 221.692% |
| GRI Bio, Inc. | -1.79 Million USD | -11049.554% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2126.672% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -501.446% |
| IGM Biosciences, Inc. | -72.6 Million USD | -175.491% |
| INmune Bio, Inc. | -25.41 Million USD | -687.151% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 232.509% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -294.842% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1130.958% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -6833.384% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 626.169% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -385.67% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 727.326% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 152.923% |
| Verastem, Inc. | -37.27 Million USD | -436.571% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2104.596% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -285.683% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1221.592% |
| Histogen Inc. | -7.48 Million USD | -2571.604% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -825.74% |
| Surrozen, Inc. | -32.66 Million USD | -512.365% |
| Organovo Holdings, Inc. | -1.5 Million USD | -13172.926% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4658.501% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1154.962% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 7746.139% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4912.873% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2286.582% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -360.437% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1272.195% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 36.859% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -27601.715% |
| Apollomics, Inc. | -27.39 Million USD | -630.144% |
| Amarin Corporation plc | -191.04 Million USD | -4.702% |
| Mesoblast Limited | 55.96 Million USD | 457.42% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1271.524% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -690.855% |
| Synaptogenix, Inc. | -28.66 Million USD | -597.88% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -21269.979% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 510.455% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -23102.129% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2652.832% |
| Exelixis, Inc. | -73.05 Million USD | -173.817% |
| Better Therapeutics, Inc. | -860 Thousand USD | -23158.488% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -732.978% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 17.13% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 27274.601% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2589.155% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 16050.797% |
| Gritstone bio, Inc. | 39.49 Million USD | 606.516% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -137.837% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -7499.254% |
| Avid Bioservices, Inc. | 169.72 Million USD | 217.849% |
| Insmed Incorporated | 721.62 Million USD | 127.719% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2088.073% |
| MediWound Ltd. | -5.32 Million USD | -3658.418% |
| OmniAb, Inc. | 9.2 Million USD | 2273.454% |
| Alector, Inc. | -35.63 Million USD | -461.279% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 332.663% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3958.908% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1610.862% |
| Zai Lab Limited | -775 Million USD | 74.191% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 158.734% |
| Aura Biosciences, Inc. | -21.52 Million USD | -829.259% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -142.511% |
| Immunic, Inc. | -45.34 Million USD | -341.162% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -3.524% |
| Veracyte, Inc. | -203.82 Million USD | 1.865% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 131.337% |
| FibroGen, Inc. | 56.76 Million USD | 452.358% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2346.188% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -6975.246% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -9561.323% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 104.357% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -5886.92% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -20.522% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1219.824% |
| Galecto, Inc. | -21.21 Million USD | -842.793% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -740.963% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 112.745% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -717.355% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1638.272% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -137.837% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4517.469% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -467.232% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -159.037% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3614.725% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -17.374% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -116.536% |
| Vaxxinity, Inc. | 10.13 Million USD | 2074.171% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 127.167% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1757.646% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -203.267% |
| NexImmune, Inc. | -3.13 Million USD | -6283.082% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -5693.28% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1223.652% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -638.092% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2128.407% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -160464.319% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -393.007% |
| Ainos, Inc. | 4.07 Million USD | 5005.015% |
| Pluri Inc. | 22.82 Million USD | 976.179% |
| Prothena Corporation plc | -608.34 Million USD | 67.12% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -68.432% |
| Celularity Inc. | 65.19 Million USD | 406.831% |
| Rallybio Corporation | -24.1 Million USD | -729.902% |
| Cue Biopharma, Inc. | -33.81 Million USD | -491.452% |
| MeiraGTx Holdings plc | -40.3 Million USD | -396.31% |
| Omeros Corporation | 331.17 Million USD | 160.398% |
| Humacyte, Inc. | -22.48 Million USD | -789.545% |
| Immunocore Holdings plc | -358.59 Million USD | 44.22% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -713.929% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -547.303% |
| Blueprint Medicines Corporation | 702.83 Million USD | 128.459% |
| CalciMedica, Inc. | -5.53 Million USD | -3517.052% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -6.271% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1858.322% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -399.595% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -501.519% |
| Pulmatrix, Inc. | -10.41 Million USD | -1820.159% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3246.545% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -424.417% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -79.551% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -233.683% |
| Cytokinetics, Incorporated | 642.37 Million USD | 131.138% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3335.051% |
| Nutriband Inc. | -251.65 Thousand USD | -79382.391% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -486.251% |
| Vor Biopharma Inc. | 4.3 Million USD | 4751.698% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.686% |
| Evogene Ltd. | -19.63 Million USD | -918.758% |
| ProKidney Corp. | -56.23 Million USD | -255.685% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -310.961% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2065.41% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 114.665% |
| CorMedix Inc. | -43.05 Million USD | -364.602% |
| BioLineRx Ltd. | 7.33 Million USD | 2826.595% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -628.283% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 533.447% |
| Atai Life Sciences N.V. | -28.55 Million USD | -600.41% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 9067.514% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -776.679% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1227.843% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -166.434% |
| MediciNova, Inc. | -50.78 Million USD | -293.874% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -153.82% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -889088.709% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2999.888% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -0.101% |
| Biomea Fusion, Inc. | -166.57 Million USD | -20.083% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -11.76% |
| Mereo BioPharma Group plc | -51.46 Million USD | -288.628% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -110.897% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 31.909% |
| Absci Corporation | -72.59 Million USD | -175.521% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4480.705% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 14.679% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -112.314% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -109.019% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -411.921% |
| Allakos Inc. | -24.97 Million USD | -700.893% |
| Imunon, Inc. | -4.21 Million USD | -4646.797% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1256.824% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -47.727% |
| BioAtla, Inc. | -109.01 Million USD | -83.489% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 27274.601% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -21201.704% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1771.595% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -843.371% |
| XOMA Corporation | -29 Million USD | -589.734% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1107.868% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2118.534% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2585.233% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -60.486% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 3.911% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -144.59% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -115.628% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -23180.578% |
| Akari Therapeutics, Plc | -3.84 Million USD | -5102.159% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 12425.111% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 114.485% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -16735.04% |
| UroGen Pharma Ltd. | 4.39 Million USD | 4655.295% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 276.261% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 278056.421% |
| Orgenesis Inc. | 21.78 Million USD | 1018.211% |
| Entera Bio Ltd. | -10.62 Million USD | -1781.861% |
| GH Research PLC | -78.07 Million USD | -156.187% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -797.447% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -650.302% |
| Xencor, Inc. | 29.64 Million USD | 774.75% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -10054.421% |
| Replimune Group, Inc. | 1.41 Million USD | 14265.935% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -81572.71% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -58.225% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -16735.04% |
| Portage Biotech Inc. | -4.98 Million USD | -3915.72% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -889088.709% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -202.506% |
| OncoCyte Corporation | -6.56 Million USD | -2947.737% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 22388.846% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4290.665% |
| Purple Biotech Ltd. | -14.13 Million USD | -1314.79% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -741.989% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2956.119% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1098.305% |
| HilleVax, Inc. | -165.48 Million USD | -20.871% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -7781.127% |
| Tharimmune, Inc. | -10.93 Million USD | -1729.141% |
| Genprex, Inc. | -6.73 Million USD | -2868.745% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 45.765% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -126.117% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -14177.159% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -5930.336% |
| OKYO Pharma Limited | -826.84 Thousand USD | -24091.024% |
| Savara Inc. | 153 Thousand USD | 130833.987% |
| Curis, Inc. | -23.88 Million USD | -737.372% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3777.985% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -25675.761% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3122.02% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 16979.578% |
| BeiGene, Ltd. | -2.25 Billion USD | 91.122% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1721.129% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 67.113% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -7.779% |
| Erasca, Inc. | -37.21 Million USD | -437.465% |
| bluebird bio, Inc. | 108.57 Million USD | 284.232% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -15431.026% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 152.812% |
| DBV Technologies S.A. | -126.98 Million USD | -57.516% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -15431.026% |
| Moderna, Inc. | -2.9 Billion USD | 93.119% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1832.216% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1740.477% |
| Molecular Templates, Inc. | 707 Thousand USD | 28391.796% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -537.605% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 157.709% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -143.746% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -118.056% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -519.804% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -481.868% |
| MacroGenics, Inc. | -66.98 Million USD | -198.609% |
| RenovoRx, Inc. | -1.17 Million USD | -16952.259% |
| Adicet Bio, Inc. | -138.78 Million USD | -44.122% |
| Prime Medicine, Inc. | -27.94 Million USD | -615.876% |
| Aditxt, Inc. | 18.12 Million USD | 1203.826% |
| Adagene Inc. | -87.62 Million USD | -128.265% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4701.98% |
| Quantum-Si incorporated | -118.55 Million USD | -68.715% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 655.542% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2576.184% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -312.342% |
| SciSparc Ltd. | -2.06 Million USD | -9586.344% |
| Vericel Corporation | 1.27 Million USD | 15763.508% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1568.012% |
| Minerva Neurosciences, Inc. | 41 Million USD | 587.81% |
| Generation Bio Co. | 31.44 Million USD | 736.044% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -14.062% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -546.842% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 271.557% |
| Invivyd, Inc. | -198.47 Million USD | -0.779% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -121.583% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -8242.327% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -182.558% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2830.74% |
| 2seventy bio, Inc. | 181.71 Million USD | 210.075% |
| ADMA Biologics, Inc. | 90.06 Million USD | 322.085% |
| Clene Inc. | 3.34 Million USD | 6088.713% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2102.241% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -829.864% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2999.888% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 41.875% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -669.329% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 212.584% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4788.665% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 4098.86% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3739.95% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -53.505% |
| Evaxion Biotech A/S | 5.28 Million USD | 3883.41% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -77.691% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -52.372% |
| Trevena, Inc. | 2.25 Million USD | 8958.415% |
| Surrozen, Inc. | -32.66 Million USD | -512.365% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -288.319% |
| Cingulate Inc. | 3.08 Million USD | 6588.601% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -6710.453% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2883.122% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2052.816% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -152.163% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -52.164% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -89.52% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4973.33% |
| Kronos Bio, Inc. | -36.05 Million USD | -454.787% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2225.869% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 13817.804% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -268.665% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1487.468% |
| ImmunityBio, Inc. | 618.22 Million USD | 132.354% |
| Korro Bio, Inc. | -132.94 Million USD | -50.458% |
| Kineta, Inc. | -4.54 Million USD | -4304.823% |
| BioVie Inc. | -17.73 Million USD | -1028.012% |
| Codexis, Inc. | -43.27 Million USD | -362.256% |
| Celularity Inc. | 65.19 Million USD | 406.831% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -6211.865% |
| Celcuity Inc. | 6.78 Million USD | 3048.666% |
| Virax Biolabs Group Limited | -3.36 Million USD | -5844.319% |
| Cibus, Inc. | -8.07 Million USD | -2376.145% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -4629.794% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 4476.871% |
| IN8bio, Inc. | -16.38 Million USD | -1120.471% |
| Kodiak Sciences Inc. | -103.87 Million USD | -92.561% |
| Annexon, Inc. | -193.75 Million USD | -3.235% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 555719.444% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1043.054% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -5593.794% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 118.973% |
| Eyenovia, Inc. | 1.25 Million USD | 15991.212% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 843.442% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6067.838% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -501.627% |
| Arcellx, Inc. | -296.95 Million USD | 32.643% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -925.443% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -239.742% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -865.036% |
| Moolec Science SA | 117.61 Thousand USD | 170164.447% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -420.907% |
| Geron Corporation | 14.76 Million USD | 1455.078% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -427.515% |
| Royalty Pharma plc | 5.65 Billion USD | 103.535% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -41.438% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2761.795% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3629.783% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -42.131% |
| Humacyte, Inc. | -22.48 Million USD | -789.545% |
| Structure Therapeutics Inc. | -124.33 Million USD | -60.869% |
| 89bio, Inc. | -289.05 Million USD | 30.801% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -692.421% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -11118.34% |
| Genelux Corporation | -6.89 Million USD | -2799.304% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -544.01% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 339.265% |
| Notable Labs, Ltd. | -9.77 Million USD | -1946.062% |
| Liquidia Corporation | -80.17 Million USD | -149.48% |
| Mustang Bio, Inc. | -3.73 Million USD | -5253.935% |
| Immunovant, Inc. | -635.22 Million USD | 68.512% |
| Quantum-Si incorporated | -118.55 Million USD | -68.715% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1038.824% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4727.975% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2591.877% |
| Acasti Pharma Inc. | -23 Million USD | -769.476% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -5840.285% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1130.958% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -45.218% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -6318.478% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -799.708% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -977.188% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -18.162% |
| PepGen Inc. | -60.67 Million USD | -229.69% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -770.574% |
| United Therapeutics Corporation | -507.7 Million USD | 60.602% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -945.817% |
| Solid Biosciences Inc. | -47.75 Million USD | -318.896% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -23102.129% |
| Immuneering Corporation | -54.94 Million USD | -264.056% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -4658.501% |
| Silo Pharma, Inc. | -3.52 Million USD | -5575.526% |
| Belite Bio, Inc | -87.27 Million USD | -129.198% |
| XOMA Corporation | -29 Million USD | -589.734% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -182.93% |
| Bionomics Limited | 227 Million USD | 188.112% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -72.015% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7796.684% |
| uniQure N.V. | -102.95 Million USD | -94.29% |
| Cassava Sciences, Inc. | -121.13 Million USD | -65.123% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -4701.98% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 588.445% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1572.293% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -6364.45% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 188800.943% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6067.838% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2346.188% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2597.182% |
| Altimmune, Inc. | -134.48 Million USD | -48.73% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 200.989% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -7796.684% |
| Compugen Ltd. | -12.9 Million USD | -1450.085% |
| Peak Bio, Inc. | 10.34 Million USD | 2034.429% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -70579.505% |
| Benitec Biopharma Inc. | -50.58 Million USD | -295.443% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -91.707% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1118.188% |
| Zura Bio Limited | -99.8 Million USD | -100.412% |
| PolyPid Ltd. | 6.17 Million USD | 3341.864% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 369.864% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1118.188% |
| Instil Bio, Inc. | 75.35 Million USD | 365.43% |
| argenx SE | -2.02 Billion USD | 90.141% |
| Immunome, Inc. | -97.02 Million USD | -106.148% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -789.189% |
| Verona Pharma plc | -220.44 Million USD | 9.263% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -178.805% |
| Shattuck Labs, Inc. | -121.42 Million USD | -64.731% |
| CervoMed Inc. | -7.79 Million USD | -2466.752% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -7.83% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -4474.045% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -51.832% |
| Moolec Science SA | 117.61 Thousand USD | 170164.447% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -8642.352% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1358.134% |
| AnaptysBio, Inc. | -18.15 Million USD | -1001.994% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1002.055% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -184.2% |
| NeurAxis, Inc. | 145.7 Thousand USD | 137384.146% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1880.832% |
| Lumos Pharma, Inc. | -28.49 Million USD | -602.008% |
| Achilles Therapeutics plc | -126.92 Million USD | -57.593% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -178.805% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -30403.866% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -862.861% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 13817.804% |
| Nutriband Inc. | -251.65 Thousand USD | -79382.391% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1418.662% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2588.481% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 158.796% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 942.734% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 55.299% |
| Palisade Bio, Inc. | -12.06 Million USD | -1558.153% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -42.557% |
| Beam Therapeutics Inc. | -262.72 Million USD | 23.865% |
| Neurogene Inc. | -131.95 Million USD | -51.584% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1016.864% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3998.832% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 46.97% |
| Sesen Bio, Inc. | -112.55 Million USD | -77.714% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -100.303% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -8419.618% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -412.538% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -140.176% |
| Athira Pharma, Inc. | -88.99 Million USD | -124.747% |
| Vaccinex, Inc. | -1.28 Million USD | -15429.736% |
| HCW Biologics Inc. | 2.85 Million USD | 7101.949% |
| XOMA Corporation | -29 Million USD | -589.734% |
| Nektar Therapeutics | 210.24 Million USD | 195.14% |
| Arvinas, Inc. | -313.8 Million USD | 36.258% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 12425.111% |
| Merus N.V. | -192.88 Million USD | -3.701% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 433.455% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2783.007% |
| Rezolute, Inc. | -68.16 Million USD | -193.427% |
| Clene Inc. | 3.34 Million USD | 6088.713% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1416.82% |
| BeyondSpring Inc. | -13.75 Million USD | -1354.184% |
| Synlogic, Inc. | -6.68 Million USD | -2892.117% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 17738.713% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2265.736% |
| Peak Bio, Inc. | 10.34 Million USD | 2034.429% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -142.687% |
| Krystal Biotech, Inc. | -350.23 Million USD | 42.889% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 261.146% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -18.36% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -6235.568% |
| MannKind Corporation | 143.89 Million USD | 239.002% |
| Ikena Oncology, Inc. | -109.15 Million USD | -83.245% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2541.963% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -504.299% |
| Gossamer Bio, Inc. | 180.35 Million USD | 210.905% |
| CohBar, Inc. | -5.93 Million USD | -3272.653% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -572.391% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4480.705% |
| Legend Biotech Corporation | -949.39 Million USD | 78.932% |
| Mural Oncology plc | -255.84 Million USD | 21.818% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 720.9% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -4146.194% |
| Disc Medicine, Inc. | -358.28 Million USD | 44.171% |
| Champions Oncology, Inc. | 4.81 Million USD | 4256.754% |
| REGENXBIO Inc. | 54.76 Million USD | 465.219% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -74283.709% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -32.445% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2119.517% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -147.912% |
| Vaxart, Inc. | -8.24 Million USD | -2327.169% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -298.611% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -57.293% |
| Cellectis S.A. | -43.85 Million USD | -356.101% |
| Longeveron Inc. | -2.9 Million USD | -6778.37% |
| Repare Therapeutics Inc. | -107.85 Million USD | -85.45% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 120.655% |
| Inozyme Pharma, Inc. | 12 Million USD | 1766.303% |
| Revolution Medicines, Inc. | -608.2 Million USD | 67.113% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -16162.033% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 24.553% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -33.285% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1178.347% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -26930.135% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.909% |
| Denali Therapeutics Inc. | -74.86 Million USD | -167.178% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1568.012% |
| Veru Inc. | 4.77 Million USD | 4284.609% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1678.615% |
| Cingulate Inc. | 3.08 Million USD | 6588.601% |
| Passage Bio, Inc. | 4.58 Million USD | 4462.552% |
| Context Therapeutics Inc. | -14.44 Million USD | -1284.259% |
| Exicure, Inc. | 5.84 Million USD | 3519.781% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 13.175% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -405.492% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1374.763% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -240.054% |
| Nuvalent, Inc. | -335.38 Million USD | 40.361% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 11633.084% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -168.552% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2149.978% |
| OmniAb, Inc. | 9.2 Million USD | 2273.454% |
| Anew Medical, Inc. | 1.43 Million USD | 14063.552% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1321.011% |
| Lipocine Inc. | -4.75 Million USD | -4106.944% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -82.124% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1413.262% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -294.842% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 903.563% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2876.09% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -203.862% |
| Ocugen, Inc. | -32.52 Million USD | -515.058% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -133.74% |
| Q32 Bio Inc. | -37.94 Million USD | -427.098% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -31750.796% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1378.476% |
| Equillium, Inc. | -22.39 Million USD | -793.279% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -682.318% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -513.064% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -80582.089% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 249.224% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 6354.628% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 61000.74% |
| Dominari Holdings Inc. | 195 Thousand USD | 102675.897% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3697.73% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2143.165% |
| Bio-Techne Corporation | 267.74 Million USD | 174.706% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1134.024% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -69.376% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2280.376% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1481.084% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 18.398% |
| Nkarta, Inc. | 57.29 Million USD | 449.086% |
| BioCardia, Inc. | 212 Thousand USD | 94450.472% |
| Iterum Therapeutics plc | 13.43 Million USD | 1588.488% |